Home › Blog › Regenexx Reaches 769 Unique Stem Cell Procedures as of 1/15/10

stem cell complications side effects

I’m spending the day working on our second large scale complications reporting paper and will spend next week with our now full time research assistant on continued analysis of knee vs. hip outcome data.  Just a quick note to report that as of 1/15/10, we have performed 769 orthopedic procedures with the patient’s own cultured, autologous mesenchymal stem cells.  I’m also proud to say that we have lost very, very few patients to active, clinic initiated, follow-up (meaning they will no longer respond regarding possible complications).  Also, as of that date, above I have included one of the charts from the upcoming paper showing number of procedures we have performed by body area.  I’m also proud to say that this upcoming publication will show that the safety profile of these 769 procedures far exceeds traditional surgical options.  Time to get back to paper writing…

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile